ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis. 2017

Linshan Hu, and Shan Liang, and Hu Chen, and Tao Lv, and Junfeng Wu, and Deshi Chen, and Min Wu, and Shengnan Sun, and Haibo Zhang, and Han You, and Hongbin Ji, and Yujun Zhang, and Johann Bergholz, and Zhi-Xiong Jim Xiao
Center of Growth, Metabolism and Aging, Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, State Key Laboratory of Biotherapy, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, China.

Activation of phosphatidylinositol 3 kinase (PI3K), Ras, and Her2 signaling plays a critical role in cancer development. Hotspot constitutive activating mutations in oncogenes, such as PIK3CA encoding the p110α catalytic subunit or RAS, as well as overexpression of Her2, are frequently found in human tumors and cancers. It has been well established that activation of these oncogenes profoundly promotes tumor metastasis, whereas decreased expression of ΔNp63α, the major protein isoform of the p53-related p63 expressed in epithelial cells, has been associated with cancer metastasis. In this study, we demonstrate that hotspot oncogenic mutations on PIK3CA and RAS, including p110αH1047R, K-RasG12V, and H-RasG12V, as well as activation of Her2, all led to suppression of ΔNp63α expression via Akt-fork-head transcription factor 3a (Akt-FOXO3a) signaling, resulting in increased cell motility and tumor metastasis. Expression of ΔNp63α effectively reversed p110αH1047R-, K-RasG12V-, H-RasG12V-, or Her2-induced cell motility in vitro and tumor metastasis in mouse models. We show that ΔNp63α was a direct FOXO3a transcriptional target and that expression of FOXO3a and ΔNp63α was correlated in human cancer biopsy samples. Together, these results demonstrate that ΔNp63α is a common inhibitory target of oncogenic PI3K, Ras, and Her2, and that ΔNp63α may function as a critical integrator of oncogenic signaling in cancer metastasis.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011905 Genes, ras Family of retrovirus-associated DNA sequences (ras) originally isolated from Harvey (H-ras, Ha-ras, rasH) and Kirsten (K-ras, Ki-ras, rasK) murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both H-ras and K-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related N-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein. Ha-ras Genes,Ki-ras Genes,N-ras Genes,c-Ha-ras Genes,c-Ki-ras Genes,c-N-ras Genes,ras Genes,v-Ha-ras Genes,v-Ki-ras Genes,H-ras Genes,H-ras Oncogenes,Ha-ras Oncogenes,K-ras Genes,K-ras Oncogenes,Ki-ras Oncogenes,N-ras Oncogenes,c-H-ras Genes,c-H-ras Proto-Oncogenes,c-Ha-ras Proto-Oncogenes,c-K-ras Genes,c-K-ras Proto-Oncogenes,c-Ki-ras Proto-Oncogenes,c-N-ras Proto-Oncogenes,ras Oncogene,v-H-ras Genes,v-H-ras Oncogenes,v-Ha-ras Oncogenes,v-K-ras Genes,v-K-ras Oncogenes,v-Ki-ras Oncogenes,Gene, Ha-ras,Gene, Ki-ras,Gene, v-Ha-ras,Gene, v-Ki-ras,Genes, Ha-ras,Genes, Ki-ras,Genes, N-ras,Genes, v-Ha-ras,Genes, v-Ki-ras,H ras Genes,H ras Oncogenes,H-ras Gene,H-ras Oncogene,Ha ras Genes,Ha ras Oncogenes,Ha-ras Gene,Ha-ras Oncogene,K ras Genes,K ras Oncogenes,K-ras Gene,K-ras Oncogene,Ki ras Genes,Ki ras Oncogenes,Ki-ras Gene,Ki-ras Oncogene,N ras Genes,N ras Oncogenes,N-ras Gene,N-ras Oncogene,c H ras Genes,c H ras Proto Oncogenes,c Ha ras Genes,c Ha ras Proto Oncogenes,c K ras Genes,c K ras Proto Oncogenes,c Ki ras Genes,c Ki ras Proto Oncogenes,c N ras Genes,c N ras Proto Oncogenes,c-H-ras Gene,c-H-ras Proto-Oncogene,c-Ha-ras Gene,c-Ha-ras Proto-Oncogene,c-K-ras Gene,c-K-ras Proto-Oncogene,c-Ki-ras Gene,c-Ki-ras Proto-Oncogene,c-N-ras Gene,c-N-ras Proto-Oncogene,ras Gene,ras Oncogenes,v H ras Genes,v H ras Oncogenes,v Ha ras Genes,v Ha ras Oncogenes,v K ras Genes,v K ras Oncogenes,v Ki ras Genes,v Ki ras Oncogenes,v-H-ras Gene,v-H-ras Oncogene,v-Ha-ras Gene,v-Ha-ras Oncogene,v-K-ras Gene,v-K-ras Oncogene,v-Ki-ras Gene,v-Ki-ras Oncogene
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071316 Forkhead Box Protein O3 A forkhead box transcription factor and transcriptional activator which triggers type 1 programmed cell death (APOPTOSIS) in the absence of APOPTOSIS INHIBITING PROTEINS, including neuronal cell death induced by OXIDATIVE STRESS. It recognizes and binds to the DNA sequence 5'-(AG)TAAA(TC)A-3' and also functions in post-transcriptional regulation of the c-MYC PROTO-ONCOGENE. FOXO3 Protein,Forkhead in Rhabdomyosarcoma-Like 1 Protein,Forkhead in Rhabdomyosarcoma Like 1 Protein,Protein, FOXO3
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription

Related Publications

Linshan Hu, and Shan Liang, and Hu Chen, and Tao Lv, and Junfeng Wu, and Deshi Chen, and Min Wu, and Shengnan Sun, and Haibo Zhang, and Han You, and Hongbin Ji, and Yujun Zhang, and Johann Bergholz, and Zhi-Xiong Jim Xiao
August 2013, Oncogene,
Linshan Hu, and Shan Liang, and Hu Chen, and Tao Lv, and Junfeng Wu, and Deshi Chen, and Min Wu, and Shengnan Sun, and Haibo Zhang, and Han You, and Hongbin Ji, and Yujun Zhang, and Johann Bergholz, and Zhi-Xiong Jim Xiao
April 2004, Seminars in cancer biology,
Linshan Hu, and Shan Liang, and Hu Chen, and Tao Lv, and Junfeng Wu, and Deshi Chen, and Min Wu, and Shengnan Sun, and Haibo Zhang, and Han You, and Hongbin Ji, and Yujun Zhang, and Johann Bergholz, and Zhi-Xiong Jim Xiao
October 2015, Oncotarget,
Linshan Hu, and Shan Liang, and Hu Chen, and Tao Lv, and Junfeng Wu, and Deshi Chen, and Min Wu, and Shengnan Sun, and Haibo Zhang, and Han You, and Hongbin Ji, and Yujun Zhang, and Johann Bergholz, and Zhi-Xiong Jim Xiao
August 2014, The Journal of clinical investigation,
Linshan Hu, and Shan Liang, and Hu Chen, and Tao Lv, and Junfeng Wu, and Deshi Chen, and Min Wu, and Shengnan Sun, and Haibo Zhang, and Han You, and Hongbin Ji, and Yujun Zhang, and Johann Bergholz, and Zhi-Xiong Jim Xiao
March 2005, Biological chemistry,
Linshan Hu, and Shan Liang, and Hu Chen, and Tao Lv, and Junfeng Wu, and Deshi Chen, and Min Wu, and Shengnan Sun, and Haibo Zhang, and Han You, and Hongbin Ji, and Yujun Zhang, and Johann Bergholz, and Zhi-Xiong Jim Xiao
January 1990, Cancer investigation,
Linshan Hu, and Shan Liang, and Hu Chen, and Tao Lv, and Junfeng Wu, and Deshi Chen, and Min Wu, and Shengnan Sun, and Haibo Zhang, and Han You, and Hongbin Ji, and Yujun Zhang, and Johann Bergholz, and Zhi-Xiong Jim Xiao
October 2014, Molecular cancer research : MCR,
Linshan Hu, and Shan Liang, and Hu Chen, and Tao Lv, and Junfeng Wu, and Deshi Chen, and Min Wu, and Shengnan Sun, and Haibo Zhang, and Han You, and Hongbin Ji, and Yujun Zhang, and Johann Bergholz, and Zhi-Xiong Jim Xiao
August 2004, The Journal of biological chemistry,
Linshan Hu, and Shan Liang, and Hu Chen, and Tao Lv, and Junfeng Wu, and Deshi Chen, and Min Wu, and Shengnan Sun, and Haibo Zhang, and Han You, and Hongbin Ji, and Yujun Zhang, and Johann Bergholz, and Zhi-Xiong Jim Xiao
February 2008, Molecular interventions,
Linshan Hu, and Shan Liang, and Hu Chen, and Tao Lv, and Junfeng Wu, and Deshi Chen, and Min Wu, and Shengnan Sun, and Haibo Zhang, and Han You, and Hongbin Ji, and Yujun Zhang, and Johann Bergholz, and Zhi-Xiong Jim Xiao
July 2007, The Journal of cell biology,
Copied contents to your clipboard!